Literature DB >> 15177536

Medical management of severe ulcerative colitis.

Justin C Chang1, Russell D Cohen.   

Abstract

The medical management of patients with severe ulcerative colitis requires initial stabilization, careful and repeated evaluations to exclude confounding or coexisting diagnoses, and timely delivery of appropriate medications. Medical therapies for these patients are potent but may be toxic, and administration must be done by experienced medical professionals, with adequate access to appropriate laboratory, radiographic, endoscopic, and surgical facilities. Patients who fail to respond to high-dose intravenous corticosteroids in a timely basis should be evaluated for cyclosporin therapy, or proceed to surgery. The promise of newer, investigational therapies to induce and maintain remission must be borne out by large controlled trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177536     DOI: 10.1016/j.gtc.2004.02.005

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  6 in total

1.  Do we know how to use corticosteroids in acute severe ulcerative colitis?

Authors:  Mohammed S Islam; Stephen L Grainger
Journal:  Frontline Gastroenterol       Date:  2012-08-11

2.  The Role of Antibiotics in Inflammatory Bowel Disease.

Authors:  Chandrashekhar Thukral; Win J Travassos; Mark A Peppercorn
Journal:  Curr Treat Options Gastroenterol       Date:  2005-06

3.  Infliximab: Use in Inflammatory Bowel Disease.

Authors:  Win J Travassos; Adam S Cheifetz
Journal:  Curr Treat Options Gastroenterol       Date:  2005-06

4.  Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis.

Authors:  Tsung-Chieh Shih; Sen-Yung Hsieh; Yi-Yueh Hsieh; Tse-Chin Chen; Chien-Yu Yeh; Chun-Jung Lin; Deng-Yn Lin; Cheng-Tang Chiu
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

5.  Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.

Authors:  Hrishikesh Samant; Devendra Desai; Philip Abraham; Anand Joshi; Tarun Gupta; Alpa Dherai; Tester Ashavaid
Journal:  Indian J Gastroenterol       Date:  2015-11-21

6.  Pretreatment of Gymnema sylvestre revealed the protection against acetic acid-induced ulcerative colitis in rats.

Authors:  Abdulaziz M Aleisa; Salim S Al-Rejaie; Hatem M Abuohashish; Mohammed S Ola; Mihir Y Parmar; Mohammed M Ahmed
Journal:  BMC Complement Altern Med       Date:  2014-02-10       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.